Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

12.18
+0.28002.35%
Post-market: 12.15-0.0300-0.25%18:22 EDT
Volume:542.93K
Turnover:6.66M
Market Cap:605.54M
PE:-3.27
High:12.52
Open:12.00
Low:11.99
Close:11.90
Loading ...
Mar 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 27, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 08, 2022

Major Issues Report

8-K - Current report
Oct 17, 2022

Major Issues Report

8-K - Current report
Sep 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 08, 2022

Major Issues Report

8-K - Current report